Evaluation of e New Sleep Detection Device "Easy Sleep Monitoring" (ESM)

January 13, 2023 updated by: University Hospital, Clermont-Ferrand

Évaluation d'un Dispositif de détection du Sommeil " Easy Sleep Monitoring " (ou " Couette Intelligente ") Par Rapport à la vidéo-polysomnographie, Chez Des Patients Avec Des Troubles du Sommeil et Des Sujets Sains

If the video-polysomnographic (vPSG) recording in the laboratory remains the reference examination in Sleep Medicine Centers for the diagnosis of sleep pathologies, the high prevalence of sleep disorders in the general population and the growing demand for exploration and management may require the use of alternative techniques such as new sleep recording or analysis devices. In collaboration with the Creative Mechatronics Company (Issoire) and the Ennery Confection Company (Le Puy en Velay), we have developed a "portable" sleep detection prototype called Easy Sleep Monitoring (ESM) which consists of an "intelligent" duvet equipped with a series of sensors capable of detecting movements and, through this, estimating sleep duration and quantifying motor phenomena during sleep. Indeed, it is a duvet which has in its thickness a grid of 35 electronic cards, equipped with an actimetric sensor and a temperature sensor. The distribution of the sensors makes it possible to detect the motor activity of the sleeper on all the body regions by considerably increasing the sensitivity and specificity compared to actimetry at the wrist.

The advantage of this duvet compared to other "wearable" devices is represented by its ease of use, being less restrictive, having a reduced implementation time and not requiring the user's collaboration. For example, it could be used for sleep monitoring in the elderly and/or in a situation of hypomobility in the context of Residential establishment for dependent elderly people or hospitals. At home, it could be a sleep monitoring tool, such as monitoring treatment for insomnia, medicinal or not, or to monitor motor activity during sleep, as in the monitoring of nocturnal akinesia in parkinsonian patients.

The main objective of this study is to evaluate the concordance of sleep data obtained with the ESM duvet with those obtained by video-polysomnography (vPSG). Indeed, the vPSG is the gold standard examination in the study of sleep, the only one capable of exactly defining the different stages of sleep and precisely quantifying sleep disorders.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Type of study : monocentric study, a proof of concept study of a new device for sleep detection "Easy Sleep Monitoring" (ESM). This is a category 4.4 clinical investigation with a non-CE marked medical device used in its indication, without the objective of CE marking or establishing compliance

Number of centers: 1

Patients:

This study will be perdormed in 50 subjects (25 patients with sleep disorders (TS+) + 25 subjects without proven sleep disorders (TS-))

Study performance:

Each subject will have 2 visits:

  1. First visit (baseline, inclusion visit, 30 minutes) which will include:

    • Information and collection of written consent
    • Recording of demographic and clinical data (age, sex, duration of disease progression, current treatments, medical and surgical history)
    • Pittsburgh PSQI Sleep Quality Index (for TS- group only)
    • Verification of inclusion and non-inclusion criteria.
  2. Visit 2 (Month 6) (duration 1 night): The patients/controls will arrive in the evening at the Sleep Laboratory (Functional Exploration Department of the Nervous System of the Clermont-Ferrand University Hospital) to carry out complete vPSG and test the new ESM "intelligent duvet" device.

Study Type

Interventional

Enrollment (Anticipated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Clermont-Ferrand, France
        • CHU Clermont-Ferrand, UMR INSERM 1107
        • Principal Investigator:
          • Livia Fantini

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

For Sleep Disorder Group (TS+):

  • Men or women, aged 18 to 85
  • With a suspected sleep disorder (sleep apnea, restless legs syndrome RLS, syndrome of periodic leg movements during MPJS sleep, REM sleep behavior disorder, Parkinson's disease, Narcolepsy, etc.), requiring a confirmation of the diagnosis in vPSG.
  • Cooperation and understanding to strictly comply with the conditions set out in the protocol - Acceptance of the protocol and signing of a written consent
  • Affiliation to the social security system

For Control Group (TS- ):

  • Men or women, aged 18 to 85
  • Having no sleep disorder: the Pittsburgh PSQI sleep quality index (Buysse et al., 1989) must be <5.
  • Cooperation and understanding to strictly comply with the conditions set out in the protocol - Acceptance of the protocol and signing of a written consent
  • Affiliation to the social security system

Exclusion Criteria:

For Group TS+ and TS-:

  • Patients under guardianship or curatorship or safeguard of justice
  • Pregnant or breastfeeding women (given the low risk incurred, the verification will be done on simple declaration of the patient)
  • Patients with active implants
  • during a period of exclusion from another study,
  • refusing to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Patients with sleep disorders (TS+)
video polysomnography; the new ESM "intelligent duvet" device
The patients/controls will arrive in the evening at the Sleep Laboratory (Functional Exploration Department of the Nervous System of the Clermont-Ferrand University Hospital) to carry out complete vPSG and test the new ESM "intelligent duvet"device. A qualified technician will place the electrodes according to the procedures usually followed at the Sleep Center for vPSG recording. The ESM duvet will be placed on the patient's body as a blanket, instead of the blankets normally provided by the hospital. Patients/controls will be monitored overnight by an infrared video camera.
Experimental: control group without sleep disorder (TS-)
video polysomnography; the new ESM "intelligent duvet" device
The patients/controls will arrive in the evening at the Sleep Laboratory (Functional Exploration Department of the Nervous System of the Clermont-Ferrand University Hospital) to carry out complete vPSG and test the new ESM "intelligent duvet"device. A qualified technician will place the electrodes according to the procedures usually followed at the Sleep Center for vPSG recording. The ESM duvet will be placed on the patient's body as a blanket, instead of the blankets normally provided by the hospital. Patients/controls will be monitored overnight by an infrared video camera.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effective sleep duration (in minutes)
Time Frame: Month 6
evaluated by vPSG
Month 6
Effective sleep duration (in minutes)
Time Frame: Month 6
evaluated by ESM device
Month 6

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time spent in bed (in minutes)
Time Frame: Month 6
evaluated by vPSG
Month 6
Time spent in bed (in minutes)
Time Frame: Month 6
evaluated by ESM device
Month 6
Sleep efficiency (Total sleep time/Time spent in bed)
Time Frame: Month 6
evaluated by vPSG
Month 6
Sleep efficiency (Total sleep time/Time spent in bed)
Time Frame: Month 6
evaluated by ESM device
Month 6
Sleep latency (in minutes)
Time Frame: Month 6
evaluated by vPSG
Month 6
Sleep latency (in minutes)
Time Frame: Month 6
evaluated by ESM device
Month 6
Duration of sleep stages (Deep Wave Sleep vs. Paradoxical Sleep)(in minutes)
Time Frame: Month 6
evaluated by vPSG
Month 6
Duration of sleep stages (Deep Wave Sleep vs. Paradoxical Sleep) (in minutes)
Time Frame: Month 6
evaluated by ESM device
Month 6
% of sleep stages (Deep Wave Sleep vs. Paradoxical Sleep)
Time Frame: Month 6
evaluated by vPSG
Month 6
% of sleep stages (Deep Wave Sleep vs. Paradoxical Sleep)
Time Frame: Month 6
evaluated by ESM device
Month 6
Number of alarm clocks
Time Frame: Month 6
evaluated by vPSG
Month 6
Number of alarm clocks
Time Frame: Month 6
evaluated by ESM device
Month 6
Number of position changes
Time Frame: Month 6
evaluated by vPSG
Month 6
Number of position changes
Time Frame: Month 6
evaluated by ESM device
Month 6
Duration of periodic movements of the lower limbs (in minutes)
Time Frame: Month 6
evaluated by vPSG
Month 6
Duration of periodic movements of the lower limbs (in minutes)
Time Frame: Month 6
evaluated by ESM device
Month 6
Duration of Cheyne-Stokes periodic breathing (in minutes)
Time Frame: Month 6
evaluated by vPSG
Month 6
Duration of Cheyne-Stokes periodic breathing (in minutes)
Time Frame: Month 6
evaluated by ESM device
Month 6
number of obstructive and central apneas
Time Frame: Month 6
evaluated by vPSG
Month 6
number of obstructive and central apneas
Time Frame: Month 6
evaluated by ESM device
Month 6

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

January 20, 2023

Primary Completion (Anticipated)

June 30, 2025

Study Completion (Anticipated)

December 31, 2025

Study Registration Dates

First Submitted

January 5, 2023

First Submitted That Met QC Criteria

January 13, 2023

First Posted (Actual)

January 25, 2023

Study Record Updates

Last Update Posted (Actual)

January 25, 2023

Last Update Submitted That Met QC Criteria

January 13, 2023

Last Verified

December 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • RBHP 2022 FANTINI

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep Disorder

Clinical Trials on night recording

3
Subscribe